William Blair Downgrades LogicBio Therapeutics (LOGC) to Market Perform Oct 3, 2022 09:29AM
LogicBio Therapeutics to Participate in William Blair Biotech Focus Conference 2021 Jul 8, 2021 07:00AM
LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 5, 2020 11:12AM
LogicBio Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Oct 5, 2020 11:12AM
LogicBio Therapeutics (LOGC) Prices 7M Share Public Offering of Common Stock at $6/Each Oct 1, 2020 09:12AM


Oct 1, 2020 09:10AM LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
Oct 1, 2020 09:09AM LogicBio Therapeutics Announces Pricing of Public Offering of Common Stock
Sep 30, 2020 04:02PM LogicBio Therapeutics (LOGC) Announces Proposed Common Offering
Sep 30, 2020 04:01PM LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
Sep 30, 2020 04:01PM LogicBio Therapeutics Announces Proposed Public Offering of Common Stock
Nov 13, 2018 06:06AM William Blair Starts LogicBio Therapeutics (LOGC) at Outperform
Oct 24, 2018 02:00AM Arix Bioscience plc - LogicBio Announces Closing of Initial Public Offering
Oct 23, 2018 04:05PM LogicBio Therapeutics Announces Closing of Initial Public Offering
Oct 23, 2018 04:05PM LogicBio Therapeutics Announces Closing of Initial Public Offering